Elizabeth Li

机构：SangStat Medical Corporation, University of Birmingham · ORCID：0000-0001-5961-2894

发表论文 157 篇 · 总被引 5990 次 · h-index 27

代表论文

• 177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial (2025 · Annals of Oncology · 被引 5)
• Systematic review of the Lancet Commission on Global Surgery indicators with quality assessment of modelled estimates (2025 · British journal of surgery · 被引 4)
• Bariatric surgery vs. GLP-1 receptor agonists among primarily medicare and medicaid patients with diabetes: a 3-year analysis (2025 · Surgical Endoscopy · 被引 3)
• A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors (2026 · npj Precision Oncology · 被引 2)
• L-5-[11C]-glutamine PET of breast cancer: Preclinical studies in mouse models (2025 · Nuclear Medicine and Biology · 被引 2)
• The effect of delays in cancer surgery due to the COVID-19 pandemic on cancer resectability and postoperative mortality in different tumor entities (2026 · Discover Oncology · 被引 1)